Ipca Laboratories was set up in 1949 by a group of businessmen and medical professionals. In 1975, the current management took over the company. At present, the Ipca Laboratories Ltd. is a rapidly growing pharmaceutical company in India whose biggest thrust is on exports.
The main activities of Ipca Laboratories Company are to produce and market pharmaceuticals and drugs. The various products of the company include formulations, drug intermediates, and active pharmaceutical ingredients (API). Ipca Laboratories produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules. The various kinds of drug intermediates that the company manufactures include Theo bromine, Acetylthiophene, and P- Bromo Toluene. Ipca Laboratories Ltd. also produces API and it is one of the biggest producers and exporters in the world in this sector.
Ipca Laboratories products are manufactured at state-of-the-art facilities. The company has production units in Athal, Dehradun, Aurangabad, Ratlam, Indore, Kandla, and Silvassa. All manufacturing units of the Ipca Laboratories are approved by the various authorities for drug regulation such as Therapeutic Goods Administration (TGA) in Australia, Food and Drug Administration (FDA) in USA, and Medicines Control Council (MCC) in South Africa.
The net profit of the company amounted to Rs. 63.98 crore in 2005- 2006 and the next year, this figure stood at Rs. 122.23 crore. Ipca Laboratories exports its products to more than 100 countries, primarily to USA, Europe, CIS, and Asia. In 2004 and 2005, Ipca Laboratories was selected among the 200 fastest rising companies outside the USA, with sales below US$ 1 billion by Forbes - the leading USA-based business magazine.
Ipca Laboratories has become one of the leading pharmaceutical companies in India on the basis of the quality of its products. This is also the reason that the export of its product is also increasing, resulting in more profits for the company.
Contact Us 
